Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Viruses|August 28, 2021
Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 MiceJeremy R A Paull, Carolyn A Luscombe, Alex Castellarnau, et al.Virology|July 13, 2004
Effect of polyanion-resistance on HIV-1 infectionMichael D Bobardt, Mercedes Armand-Ugón, Imma Clotet, et al.Plos One|February 5, 2019
The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidateMichael Bobardt, Joseph Kuo, Udayan Chatterji, et al.Antimicrobial Agents and Chemotherapy|November 11, 2015
C5A Protects Macaques from Vaginal Simian-Human Immunodeficiency Virus ChallengeRonald S Veazey, Udayan Chatterji, Michael Bobardt, et al.Journal of Hepatology|August 21, 2012
HCV NS5A and IRF9 compete for CypA bindingMichael Bobardt, Sam Hopkins, James Baugh, et al.Antimicrobial Agents and Chemotherapy|July 18, 2012
Multiple mutations in hepatitis C virus NS5A domain II are required to confer a significant level of resistance to alisporivirJose A Garcia-Rivera, Michael Bobardt, Udayan Chatterji, et al.Antiviral Research|May 19, 2021
Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitroJeremy R A Paull, Graham P Heery, Michael D Bobardt, et al.Scientific Reports|September 11, 2024
Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epitheliumJeremy R A Paull, Carolyn A Luscombe, Aynaz Seta, et al.Immunity|January 18, 2003
Syndecan captures, protects, and transmits HIV to T lymphocytesMichael D Bobardt, Andrew C S Saphire, Hsiu-Cheng Hung, et al.Plos One|September 8, 2017
Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized micePhilippe A Gallay, Udayan Chatterji, Aaron Kirchhoff, et al.Pageof 6